Ethyl 5-amino-1-(pyrimidin-2-yl)-1H-pyrazole-4-carboxylate

Catalog No. :
ACMVFI415
CAS No. :
91129-95-2
Molecular Formula :
C10H11N5O2
Molecular Weight :
233.23

IUPAC Name:ethyl 5-amino-1-(pyrimidin-2-yl)-1H-pyrazole-4-carboxylate

Ethyl 5-amino-1-(pyrimidin-2-yl)-1H-pyrazole-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$56.00Login to see priceInquiryInquiry
1g95%$138.00Login to see priceIn stockInquiry
5g95%$497.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-amino-1-(pyrimidin-2-yl)-1H-pyrazole-4-carboxylate
IUPAC Nameethyl 5-amino-1-(pyrimidin-2-yl)-1H-pyrazole-4-carboxylate
Molecular FormulaC10H11N5O2
Molecular Weight233.23
SMILESO=C(C1=C(N)N(C2=NC=CC=N2)N=C1)OCC
InChI KeyNUJVQPYZCUMBML-UHFFFAOYSA-N
Synonymethyl 5-amino-1-(pyrimidin-2-yl)-1H-pyrazole-4-carboxylate;5-Amino-1-(2-pyrimidinyl)-1H-pyrazole-4-carboxylic acid ethyl ester;Ethyl 5-amino-1-pyrimidin-2-yl-pyrazole-4-carboxylate;5-amino-1-(pyrimidin-2-yL;1H-Pyrazole-4-carboxylic acid, 5-amino-1-(2-pyrimidinyl)-, ethyl ester
CAS No.91129-95-2
PubChem CID2337348

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMVFI415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEQJT290 route compound structure diagram
    ACEQJT29019750-02-8 In Stock
  2. Plus
  3. ACNKTZ369 route compound structure diagram
    ACNKTZ3691722-12-9 In Stock
  4. Then
  5. ACMVFI415 route product structure diagram
    ACMVFI41591129-95-2 In Stock
Inquiry

2. ACMVFI415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMVFI415 route product structure diagram
    ACMVFI41591129-95-2 In Stock
Inquiry

Comments (0)